Lower expression of endogenous intestinal alkaline phosphatase may predict worse prognosis in patients with Crohn's disease

• Published in: BMC gastroenterology 2018-12, Vol.18 (1), p.188-188, Article 188
• Main Authors: Park, Seon-Young, Kim, Ji-Young, Lee, Su-Mi, Chung, Jin Ook, Seo, Ji-Ho, Kim, SunMin, Kim, Dong Hyun, Park, Chang-Hwan, Ju, Jae-Kyun, Joo, Young-Eun, Lee, Jae-Hyuk, Kim, Hyun-Soo, Choi, Sung-Kyu, Rew, Jong-Sun
• Format: Article
• Language: English
• Subjects: Alkaline phosphatase; Biopsy; Colon; Colonoscopy; Crohn's disease; Gastroenterology; Gene expression; Homeostasis; Hospitalization; Inflammation; Inflammatory bowel disease; Interleukin 6; Intestine; mRNA; Mucosa; Phosphatase; Polymerase chain reaction; Proteins; Recurrence; Tumor necrosis factor-α
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/s12876-018-0904-x

Intestinal alkaline phosphatase (IAP) plays important role in gut homeostasis. We aimed to evaluate the expression of endogenous IAP and to assess the clinical course according to the expression of endogenous IAP in patients with Crohn's disease (CD). A total of 32 consecutive patients (14 males) with CD were included in the study. We measured the level of endogenous iAP in inflamed and noninflamed colonic mucosa. To verify the inflammation status, we measured the level of mRNA for IL-6, TNF-α, and TLR-4. We monitored the clinical courses of patients during follow-up after acquisition of biopsy specimens. Median age of patients was 22.5 years (range, 15-49). Median CD activity index (CDAI, range) was 93.7 (22.8~ 154.9). There were colonic involvements in all patients and perianal involvement in 43.8% patients. The mRNA levels of IL-6 (p = 0.005) and TLR-4 (p = 0.013) in inflamed mucosa were significantly higher than those in non-inflamed mucosa. However, there was no difference of expression of TNF-α mRNA (p = 0.345). During a 14-month follow-up (range, 9 months-54 months), there were 19 patients with clinical recurrences. There were 9 patients (9/19, 47.4%) with IAP expression ratio (inflamed to non-inflamed) ≤ 1.0 in patients with clinical recurrence while there was one patient (1/13, 7.7%) with IAP ratio ≤ 1.0 in patients without clinical recurrence (p = 0.024). Lower expression of IAP in inflamed mucosa compared to non-inflamed mucosa may be associated with clinical recurrence in patients with CD.